CONTROL OF EOSINOPHILIA

被引:28
作者
SANDERSON, CJ [1 ]
机构
[1] NATL INST MED RES,LONDON NW7 1AA,ENGLAND
来源
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY | 1991年 / 94卷 / 1-4期
关键词
D O I
10.1159/000235342
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Experiments in vitro have suggested that IL5 is a late-acting factor in eosionophil production, and that other factors such as IL3, G-CSF and GM-CSF are required for the production of committed eosinophil progenitors. Furthermore, work in vitro indicates that in addition to IL5, both IL3 and GM-CSF are capable of stimulating eosinophil differentiation. Thus, there would appear to be both considerable redundancy in cytokine actions in eosinophilia as well as a complex network of cytokine activities to induce eosinophilia. Experiments in vivo, however, suggest a less complicated control mechanism, dominated by IL5.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 20 条
[11]   THE CLINICAL AND IMMUNOLOGICAL RESPONSES OF NORMAL HUMAN VOLUNTEERS TO LOW-DOSE HOOKWORM (NECATOR-AMERICANUS) INFECTION [J].
MAXWELL, C ;
HUSSAIN, R ;
NUTMAN, TB ;
POINDEXTER, RW ;
LITTLE, MD ;
SCHAD, GA ;
OTTESEN, EA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1987, 37 (01) :126-134
[12]   MOLECULAR AND CELLULAR BIOLOGY OF EOSINOPHIL DIFFERENTIATION FACTOR (INTERLEUKIN-5) AND ITS EFFECTS ON HUMAN AND MOUSE B-CELLS [J].
SANDERSON, CJ ;
CAMPBELL, HD ;
YOUNG, IG .
IMMUNOLOGICAL REVIEWS, 1988, 102 :29-50
[13]   IDENTIFICATION OF A LYMPHOKINE THAT STIMULATES EOSINOPHIL DIFFERENTIATION INVITRO - ITS RELATIONSHIP TO INTERLEUKIN-3, AND FUNCTIONAL-PROPERTIES OF EOSINOPHILS PRODUCED IN CULTURES [J].
SANDERSON, CJ ;
WARREN, DJ ;
STRATH, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :60-74
[14]  
SANDERSON CJ, 1989, COLONY STIMULATING F, P231
[15]   INTERLEUKIN-5 IS REQUIRED FOR THE BLOOD AND TISSUE EOSINOPHILIA BUT NOT GRANULOMA-FORMATION INDUCED BY INFECTION WITH SCHISTOSOMA-MANSONI [J].
SHER, A ;
COFFMAN, RL ;
HIENY, S ;
SCOTT, P ;
CHEEVER, AW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :61-65
[16]  
STRATH M, 1986, EXP HEMATOL, V14, P16
[17]  
STRATH M, 1989, METHOD MOL BIOL, V5, P361
[18]  
WARREN DJ, 1985, IMMUNOLOGY, V54, P615
[19]  
WARREN DJ, 1988, J IMMUNOL, V140, P94
[20]   PURIFIED INTERLEUKIN-5 SUPPORTS THE TERMINAL DIFFERENTIATION AND PROLIFERATION OF MURINE EOSINOPHILIC PRECURSORS [J].
YAMAGUCHI, Y ;
SUDA, T ;
SUDA, J ;
EGUCHI, M ;
MIURA, Y ;
HARADA, N ;
TOMINAGA, A ;
TAKATSU, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :43-56